Literature DB >> 7816447

Metabolic disorders of the vestibular system.

L P Rybak1.   

Abstract

This article reviews the impact of metabolic disorders on vestibular function. Diabetes mellitus is a disorder of glucose metabolism that can be associated with vestibular dysfunction. Vertigo can be alleviated by diet management in many cases. Elevated levels of blood lipids have been implicated in cochleovestibular disorders. Treatment with a lipid-lowering drug has resulted in improved auditory and vestibular function in a placebo-controlled trial. Hypothyroidism may affect different parts of the vestibular system depending on the severity and duration of thyroid deficiency. Severe congenital hypothyroidism can cause central vestibular disorders affecting the cerebellum, whereas mild hypothyroidism may result in peripheral vestibulopathy. Endogenous alterations in concentrations of estrogen and progesterone in the premenstrual syndrome or with the use of exogenous hormones such as oral contraceptives may trigger vertigo. Metabolic evaluations for unexplained vertigo should include a lipoprotein profile, with cholesterol and triglyceride levels, glucose tolerance test, and thyroid hormone measurements. Nutritional and drug therapy may be useful to reverse the vestibular dysfunction.

Entities:  

Mesh:

Year:  1995        PMID: 7816447     DOI: 10.1016/S0194-59989570312-8

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  13 in total

1.  Culture media-based selection of endothelial cells, pericytes, and perivascular-resident macrophage-like melanocytes from the young mouse vestibular system.

Authors:  Jinhui Zhang; Songlin Chen; Jing Cai; Zhiqiang Hou; Xiaohan Wang; Allan Kachelmeier; Xiaorui Shi
Journal:  Hear Res       Date:  2017-01-11       Impact factor: 3.208

Review 2.  Diabetes and the Vestibular System.

Authors:  Erin G Piker; Daniel J Romero
Journal:  Semin Hear       Date:  2019-10-09

3.  10 years of Vertigo Clinic at National Hospital Abuja, Nigeria: what have we learned?

Authors:  Abiodun D Olusesi; J Abubakar
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-09       Impact factor: 2.503

4.  Comorbid psychiatric conditions of benign paroxysmal positional vertigo.

Authors:  Abdulrahman Hagr
Journal:  Int J Health Sci (Qassim)       Date:  2009-01

5.  Hormones and Vestibular Disorders: The Quest for Biomarkers.

Authors:  Rhizlane El Khiati; Brahim Tighilet; Stephane Besnard; Christian Chabbert
Journal:  Brain Sci       Date:  2022-05-02

Review 6.  Impact of Diabetic Complications on Balance and Falls: Contribution of the Vestibular System.

Authors:  Linda J D'Silva; James Lin; Hinrich Staecker; Susan L Whitney; Patricia M Kluding
Journal:  Phys Ther       Date:  2015-08-06

7.  The effects of diabetes and/or peripheral neuropathy in detecting short postural perturbations in mature adults.

Authors:  George D Fulk; Charles J Robinson; Sumona Mondal; Christopher M Storey; Anne M Hollister
Journal:  J Neuroeng Rehabil       Date:  2010-09-13       Impact factor: 4.262

8.  The role of thyroid and parathyroid metabolism disorders in the etiology of sudden onset dizziness.

Authors:  Ugur Lok; Sinan Hatipoglu; Umut Gulacti; Abdullah Arpaci; Nurettin Aktas; Tayfun Borta
Journal:  Med Sci Monit       Date:  2014-12-16

9.  Hypothyroidism is an independent risk factor for Menière's disease: A population-based cohort study.

Authors:  Wen-Ling Lin; Chih-Yu Chen; Tai-Yi Hsu; Wei-Kung Chen; Cheng-Li Lin; Hang-Cheng Chen
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

10.  Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model.

Authors:  Ruimin Tian; Yun Zhang; Qi Pan; Yunfeng Wang; Qianwen Wen; Xiaoping Fan; Guangcheng Qin; Dunke Zhang; Lixue Chen; Yixin Zhang; Jiying Zhou
Journal:  J Headache Pain       Date:  2022-03-08       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.